Medications in FDA's National Priority Voucher Program
Nine medications are part of the initial list of program participants.
The FDA announced the first nine companies to participate in its National Priority Voucher program.
The program aims to promote novel treatments that benefit the health interests of Americans, including medications that meet a large, unmet need or reduce downstream health care utilization.
Medications utilizing MFN pricing can also be considered for the program.
The Priority Voucher program is a new initiative to promote novel treatments that FDA believes will benefit the health interests of Americans.
Author's summary: FDA announces 9 medications in Priority Voucher program.
More News
- Borrower Monitoring, AI Processing, DPA, Verification Tools; Events and Training; Robots Will do What?
- This Hawaii Food Truck Turns Butter Garlic Shrimp Into Legend
- Manchester United’s stance on Kobbie Mainoo leaving Old Trafford in January revealed
- “We know…” - Matthijs de Ligt makes bold “belief” claim ahead of Liverpool vs Man Utd
- Brewers Go Out With a Whimper in NLCS
- Lakers' preseason darling was sadly included in flurry of roster cuts
- Sportsnet | The incredible story of Jonathan Toews return to the NHL – Illegal Curve Hockey
- EU Updates Age Verification Standards for Minors
- TBA, Appraisal, Reverse Mortgage Tools; STRATMOR on AI and Competition; Can the CFPB be Willed Away?
- “Man Utd are quite convinced…” - Fabrizio Romano reveals “complete” star will leave Old Trafford in 2026